Oftalmol Zh.2012;3:83-86

Full text Pdf 

http://doi.org/10.31288/oftalmolzh201238386

DEVIC'S SYNDROME (NEUROMYELITIS OPTICA) IN MULTIPLE SCLEROSIS

N. N. Bushuyeva, E. S. Stoianova

Odessa, Ukraine

We present a rare variant of multiple sclerosis — Devic's syndrome (neuromyelitis optica). It results in blindness and even lethal outcome in the majority causes. We have described the optimum scheme of examination of patients with suspicion on this disease and their management together with neurologists and neurosurgeons.

References

1.Гусев Е. И. Рассеянный склероз / Е. И. Гусев, Т. Л. Демина// [Кафедра неврологии и нейрохирургии РГМУ, Москва]

2.Яхно Н. Н. Оптикомиелит Девика / Н. Н. Яхно, Ю. В.Мозолевский, В. В. Голубева// Неврологический журнал. — Издательство «Медицина». — 2008. — № 2, Vol. 13 — С.27- 33.

3.Brissaud O. Multiple sclerosis: pathogenesis and manifestations in children /O. Brissaud, K. Palin, J. F. Cha¬teil, J. M. Pedespan // Arch Pediatr. — 2001. — № 8. — Vol. 9. — P.969- 78.

4.Clanet M. Jean-Martin Charcot. 1825 to 1893 /M. Clanet // MS J. — 2008. — № 15, Vol 2. — P.59-61.

5.Compston A. Multiple sclerosis / A. Compston, A. Coles // Lancet 2002. — № 359, Vol. 9313. — P.221- 1231.

6.Debouverie M. Natural history of multiple sclerosis in a population-based cohort /M. Debouverie, S. Pittion-Vouyovitch, S. Louis, F. Guillemin // Eur. J. Neurol. —2008.

7.Dyment D. A. Genetics of multiple sclerosis /D. A. Dyment, G. C. Ebers, A. D. Sadovnick// Lancet Neurol. — 2004. — № 3, Vol. 92. — P.104-10.

8.Graber D. J. Neuromyelitis optica pathogenesis and aquaporin 4. Jacob Retrospective Analysis of 25 Patients. Treatment of Neuromyelitis Optica With Rituximab / D. J. Graber, M. Levy [et al.] // Arch Neurol. — 2008. — № 65, Vol. 11. — P.1443.

9.Mandler R. N. Neuromyelitis optica — Devic's syndrome /R. N. Mandler// Autoimmun Rev. — 2006. — № 5. — P. 537- 543.

10.McDonald W. I. Multiple Sclerosis / W. I. McDonald, A. Compston// Ann Neurol. — 2001. — № 50. — P.121- 127.

11.Polman C. H. Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria / C. H. Polman, S. C. Reingold, B. Banwell // Annals of Neurology. — 2011. — № 69, Vol. 2. — P.292- 302

12.PRISMS (Prevention of Relapses and Disability by Interferon-ß-1a Subcutaneously in Multiple Sclerosis)-4: Long term efficacy on interferon beta-1a in relapsing MS (Study Group; the University of British Columbia MS/MRI Analysis Group) Neurology. — 2001. — № 56, Vol.12. — P.1628- 1629.

13.Spickett G. Oxford handbook of Clinical Immunology / G. Spickett // Oxford University Press 1999. — P.715.

14.Warlow C. P., Dennis M. S., van Gign J. et al. Stroke: a practical guide to management. 2nd Edition. Blackwell Science 2002. — P.630.